Location: Home
  • search
  • go
  • Relate News
  • 3/20/2025State Council Issues the Opinion on Enhancing TCM Quality and Promotin...
  • 3/19/2025Accropeutics Secured $12M in Series B Plus Financing
  • 3/19/2025Hengrui Initiates Phase 2/3 Trial Combining SHR-A2102 and Adebrelimab ...
  • 3/19/2025Celregen Secures ~CNY 100M in Angel+ Financing
  • 3/19/2025CSPC Initiates Phase 3 Trial of SYS6010 for EGFR-Mutant NSCLC Patients
  • 3/19/2025Visirna's VSA001 Achieves Positive Phase III Results in Treating FCS
  • 3/19/2025Teva and Kerry Form Strategic Partnership to Strengthen Pharma Supply ...
  • 3/19/2025EU Chamber Urges China to Balance Drug Procurement Priorities amid Pri...
  • 3/19/2025CDE Issues the 2024 Annual Drug Evaluation Report with Record Surge in...
  • 3/19/2025MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...
  • 3/19/2025Shanghai Breaks Ground on National Emergency Medical Center
  • 3/19/2025Rona Thera Secures $25M in Series Pre-B Financing to Advance siRNA The...
  • 3/19/2025These 12 Chinese Companies Are Poised to Transform CRISPR Gene-Editing...
  • 3/19/2025China's Healthcare Sector in 2025: Anti-Corruption and Beyond (CR)
  • 3/19/2025Trends and Projections of Hypertensive Heart Disease Burden in China: ...
  • 3/19/2025Severe Decline in County Market in 2024, Possible Rebound in 2025, wit...
  • 3/17/2025Fail to Launch: Affordable Gene Therapy from China - A Realty Within R...
  • 3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...
  • 3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China
  • 3/17/2025SinoCellTech Advances PD-1/VEGF Bispecific SCTB14 into Phase 2/3 for E...
  • 3/17/2025China Suspends Imports of Five APIs from Kyowa Hakko Bio's Hofu Plant
  • 3/17/2025NMPA Solicits Comments on Draft Revision of GMP Annex for Sterile Drug...
  • 3/17/2025Visirna Announce Positive Topline Results from Phase 3 Trial of Ploza...
  • 3/17/2025Innovent Launches GLORY-3: A Phase 3 Head-to-Head Study of Mazdutide v...
  • 3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...
  • 3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
  • 3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...
  • 3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M
  • 3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China
  • 3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...
  • Page:6/761 Total number of articles:22823: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group